No Matches Found
No Matches Found
No Matches Found
Andhra Cements Q4 FY26: Tax Credit Masks Operational Distress as Losses Mount
Andhra Cements Ltd., a micro-cap cement manufacturer operating under the Durga Prasad brand, reported a dramatic turnaround in reported net profit for Q4 FY26, posting ₹48.52 crores compared to a loss of ₹44.14 crores in Q3 FY26. However, this apparent recovery is entirely attributable to an extraordinary tax credit of ₹89.32 crores, masking continued operational hemorrhaging at the core business level. The stock gained 4.36% following the results, trading at ₹57.40 with a market capitalisation of ₹518.00 crores, but remains down 47.72% from its 52-week high of ₹109.80.
JSL Industries Q4 FY26: Strong Quarter Masks Deeper Valuation Concerns
JSL Industries Limited, the Gujarat-based electrical equipment manufacturer, reported a sharp recovery in Q4 FY26 with net profit surging to ₹1.19 crores, marking a 60.81% quarter-on-quarter increase and a remarkable turnaround from the ₹0.19 crore loss recorded in Q4 FY25. The stock responded positively, climbing 8.83% to ₹1,038.45 following the results announcement, though it remains 36.95% below its 52-week high of ₹1,647.00. With a market capitalisation of ₹112.00 crores, the micro-cap company's strong quarterly performance comes against a backdrop of stretched valuations and concerning long-term growth trends that warrant careful investor scrutiny.
Paras Defence Q4 FY26: Strong Momentum Drives 74% Profit Surge
Paras Defence and Space Technologies Ltd., a specialised aerospace and defence manufacturer, delivered an impressive fourth quarter performance for FY26, with consolidated net profit surging 74.34% year-on-year to ₹34.38 crores. The company, commanding a market capitalisation of ₹6,612 crores, demonstrated robust operational momentum with revenue growing 58.28% YoY to ₹171.31 crores in Q4 FY26.
Tube Investments Q4 FY26: Strong Revenue Growth Marred by Tax-Driven Profit Volatility
Tube Investments of India Ltd. delivered a mixed performance in Q4 FY26, with consolidated net profit plunging 48.48% quarter-on-quarter to ₹85.45 crores, despite posting its highest-ever quarterly revenue of ₹6,214.74 crores. The sharp profit decline was primarily driven by an unusually elevated tax rate of 53.40%, which overshadowed robust operational performance marked by 20.68% year-on-year revenue growth and resilient operating margins.
Ester Industries Q4 FY25: Sharp Recovery Masks Persistent Margin Pressure
Ester Industries Ltd., a manufacturer of polyester films and engineering plastics, reported a consolidated net profit of ₹7.87 crores for Q4 FY25, marking a dramatic turnaround from three consecutive quarters of losses. The micro-cap packaging company, with a market capitalisation of ₹926.00 crores, delivered a sequential recovery that saw profitability return after a challenging nine-month period that witnessed cumulative losses exceeding ₹35 crores.
Perfectpac Ltd Q4 FY26: Margin Compression Signals Operational Strain
Perfectpac Limited, a Faridabad-based manufacturer of corrugated fibreboard containers with a market capitalisation of ₹57.00 crores, reported a net profit of ₹0.77 crores for Q4 FY26, marking a sequential improvement of 13.24% from Q3 FY26's ₹0.68 crores but representing a modest year-on-year growth of 13.24% from ₹0.68 crores in Q4 FY25. The company's shares closed at ₹85.00 on May 13, 2026, down 1.16% from the previous session, reflecting investor caution despite the quarterly recovery.
Sharda Cropchem Q4 FY26: Record Quarter Drives 57% Profit Surge
Sharda Cropchem Ltd., a prominent player in India's pesticides and agrochemicals sector, delivered a stellar performance in Q4 FY26, posting consolidated net profit of ₹318.64 crores—a robust 56.53% year-on-year increase and a remarkable 119.57% quarter-on-quarter surge. The ₹10,657 crore market capitalisation company reported its highest-ever quarterly revenue of ₹2,064.90 crores, up 12.93% YoY and 60.22% QoQ, underscoring strong operational momentum as the fiscal year concluded.
GlaxoSmithKline Pharmaceuticals Q4 FY26: Margin Compression Clouds Strong ROE Performance
GlaxoSmithKline Pharmaceuticals Ltd., the Indian subsidiary of global biopharma giant GSK Plc., reported a net profit of ₹277.86 crores for Q4 FY26, marking a decline of 6.01% quarter-on-quarter whilst posting a modest 5.70% year-on-year growth. The ₹41,704 crore mid-cap pharmaceutical company's shares traded at ₹2,406.85 on May 13, down 1.68% from the previous close, reflecting investor concerns over sequential margin compression despite the company maintaining an exceptional return on equity of 55.83%.
Foseco India Q4 FY26: Stellar Profit Surge Masks Valuation Concerns
Foseco India Limited, a world leader in foundry consumables and solutions, delivered an exceptional fourth quarter performance for FY26, with consolidated net profit surging 168.33% quarter-on-quarter to ₹33.81 crores and 72.94% year-on-year. The ₹4,025 crore market capitalisation company saw its stock rally 12.28% following the results announcement, closing at ₹5,421.55 on May 13, 2026.
Smruthi Organics Q4 FY26: Profit Rebounds But Revenue Slide Continues
Smruthi Organics Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹130.00 crores, reported a sequential recovery in profitability for the quarter ending March 2026, though the underlying revenue trends remain concerning. Net profit for Q4 FY26 stood at ₹1.07 crores, marking a decline of 23.60% quarter-on-quarter from ₹1.40 crores in Q3 FY26, whilst representing a sharp 52.02% decline year-on-year from ₹2.23 crores in Q4 FY25.
New Fiat F2X Fastback SUV Spied In India - Citroen Basalt Cousin - RushLane
New Fiat F2X Fastback SUV Spied In India - Citroen Basalt Cousin - RushLane
US producer prices post biggest gain in four years in April - Reuters
US producer prices post biggest gain in four years in April - Reuters
Exclusive: LinkedIn is planning to lay off 5% of staff in latest tech-sector cuts, source says - Reuters
Exclusive: LinkedIn is planning to lay off 5% of staff in latest tech-sector cuts, source says - Reuters
OneSource Specialty Pharma Q4 FY26: Margin Collapse Masks Revenue Recovery
OneSource Specialty Pharma Ltd., a small-cap pharmaceutical company with a market capitalisation of ₹20,747 crores, reported a dramatic 95.33% year-on-year decline in consolidated net profit to ₹4.60 crores for Q4 FY26, despite achieving modest revenue growth. The stock has declined 2.34% following the results announcement, reflecting investor concerns over profitability erosion even as the company managed to recover from the previous quarter's substantial losses.
Stallion India Fluorochemicals Q4 FY26: Profit Resilience Masks Revenue Decline
Stallion India Fluorochemicals Ltd. reported a mixed performance for the quarter ended March 2026 (Q4 FY26), with net profit declining 17.64% quarter-on-quarter to ₹10.93 crores whilst revenue fell 27.43% year-on-year to ₹109.99 crores. The micro-cap chemical company, valued at ₹1,697 crores, faces mounting pressure as its stock plunged 4.72% following the results announcement, trading at ₹140.15 and extending its year-to-date decline to 30.02%.
Pyramid Technoplast Q4 FY26: Strong Quarter Masks Underlying Margin Pressures
Pyramid Technoplast Ltd., a micro-cap packaging company with a market capitalisation of ₹657.00 crores, reported a robust fourth quarter performance for FY26, with net profit surging 51.58% quarter-on-quarter to ₹10.02 crores. However, the impressive headline numbers conceal persistent margin challenges that have plagued the company throughout the fiscal year, raising questions about the sustainability of profitability improvements.
Flora Corporation Q4 FY26: Profits Surge Despite Revenue Contraction as Trading Firm Faces Volatility Concerns
Flora Corporation Ltd., a micro-cap trading and distribution firm with a market capitalisation of ₹7.00 crores, reported a dramatic swing to profitability in Q4 FY26 with net profit of ₹4.20 crores, reversing from losses in the previous two quarters. However, the profit surge came against a backdrop of sharply declining revenues, which fell 47.30% year-on-year to ₹26.15 crores, raising questions about the sustainability and quality of earnings at this volatile small-cap stock currently trading at ₹7.80.
Jet Freight Logistics Q4 FY26: Stellar Quarter Masks Underlying Structural Concerns
Jet Freight Logistics Ltd., a Mumbai-based freight forwarding and logistics solutions provider, delivered an impressive fourth quarter performance for FY26, with net profit surging 185.19% quarter-on-quarter to ₹3.08 crores from ₹1.08 crores in Q3 FY26. Year-on-year growth was even more remarkable at 805.88%, as the company posted ₹0.34 crores in Q4 FY25. Following the results announcement, the stock rallied 10.08% to close at ₹21.19 on May 13, 2026, pushing its market capitalisation to ₹90.00 crores.
Kirloskar Brothers Q4 FY26: Margin Pressure Weighs on Profitability Despite Revenue Growth
Kirloskar Brothers Ltd., the century-old engineering powerhouse specialising in fluid-handling equipment and turnkey projects, reported a mixed performance for the quarter ended March 2026, with robust revenue growth offset by concerning margin compression. The company posted a consolidated net profit of ₹111.50 crores for Q4 FY26, marking a sequential decline of 10.30% from ₹124.30 crores in Q3 FY26 and a year-on-year drop of 18.67% from ₹137.10 crores in Q4 FY25. The stock reacted sharply to the results, plunging 5.88% to close at ₹1,583.35 on May 13, 2026, reflecting investor concerns over profitability trends despite the company's market capitalisation standing at ₹13,373 crores.

